Subject(s)

Adult , Female , Humans , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Signet Ring Cell/drug therapy , Quality of Life , Stomach Neoplasms/drug therapy , Carcinoma, Signet Ring Cell/secondary , Cisplatin/administration & dosage , Esophageal Neoplasms/pathology , Floxuridine/administration & dosage , Infusions, Intravenous , Liver Neoplasms/secondary , Lymphatic Metastasis , Neoplasm Invasiveness , Stomach Neoplasms/pathology